1300+
Attendees

100+
Speakers

90+
Exhibitors

40+
Patients

6
Stages

To become a health innovator, we have to realign mindsets around the outcomes-dependent, patient-first business reality of tomorrow.

This means going beyond the needs of our company and working with stakeholders to harness the greatest value possible. To get there we must overcome hurdles that still persist when gaining internal and external support.

The end result…better outcomes, prescription numbers and patient adherence.

The im-patient conference at Barcelona

An idea was born

In 2018 we had an idea. Let’s host a pharmaceutical conference - except this time, patients will be the designers, creators and hosts!

The rationale

There are plenty of pharmaceutical conferences, many of which claim to be ‘patient-centric’. However, they are all run with one basic assumption: that pharma companies know what patients want, and that pharma companies should set the agenda.

Beyond conferences

After 2 successful iterations (in Europe and North America) we’re now bringing im-patient to Barcelona 2019 – where its industry changing impact can be felt the most.

No longer is the industry in the driving seat. With patient there instead, we can capture the true essence of what patient-centricity means – with the most important topics, speakers and discussion formats all chosen by the steering board.

Our Patient Promise

This patient focus has become commonplace over the past few years, and it’s easy to think that it’s a straightforward thing to do. But patient focus runs much deeper than that; it is not simply compassion.

As an organiser of industry events and published articles, we have a responsibility to ensure the patient voice is heard and understood. We also have an opportunity to magnify the patient voice so it can be received by many. So the involvement of patients in our conferences is essential.

To create this Patient Policy, we have consulted with patients to understand how to accommodate everyone at our events.

New for 2019

The Innovation Stage

A showcase of bleeding-edge, industry-transforming science and new ideas which will open your eyes to the coming disruptions.

BiographyMatthew Eagles

In chairing the first ever #im-patient conference in London and being part of an extremely talented and motivated European Steering Committee the standing ovation we received showed a palpable desire for pharma to want to co-create with patients and this relationship needs to be carefully nurtured when time is available. I genuinely believe we have taken very important steps to creating a relationship that is incredibly special and will change hearts and minds.

BiographyCarole Sian Scrafton

As a Founding supporter of im-patient, Patient Leader/Expert & Ambassador I have a unique set of skillsets including being a certified business professional.

One of Five Founding members of a patient-led support group, and also as CEO of a chronic illness portal designed for #patients & #notjustpatients sharing across all areas of medical healthcare industries. A key driver behind change to pharma-patient relationships, patient-centricity, and multidisciplinary approaches including all stakeholders.

BiographyAlan Thomas

Founder of Ataxia and me - a patient focused rare disease support group. Based in West Wales with a global following very focused to give the patient voice to the community. Alan is a patient engagement advocate for rare diseases in general and Ataxia in particular. He is known as the 'rare disease warrior' and, as a patient with a 'life-limiting' rare disease, he can convey the patient engagement message from his point of view in all issues regarding the wellbeing of patients.

Alan has established a patient-driven and focused group and campaigns at many levels, including patient forums, local and regional health boards, Welsh/UK government organisations, as well as taking part in many global conferences, in person or via the internet.

BiographyBirgit Bauer

I am living with MS for almost 14 years. I am blogger about MS and healthcare since 2007, I do it for free and I am one of the most influential bloggers in Germany and Europe about it. I am doing a lot of things at the EMA, for EMSP and for my community (last but not least, because they are a part of my power) and also I graduated as Eupati Fellow in 2015 as first MS Patient and the first German Patient Advocate. I am also Journalist, Speaker and Digital Expert.

BiographyElly Aylwin-Foster

I am a writer, digital strategist and lifelong patient. I am writing a book about the shared experience of people with chronic illness, and carry out patient advocacy at professionalsickgirl.com. My work has been published in The Independent and The Mighty. My career background is in communications and market research, I'd love to put these skills to use for im-patient, in whatever way needed.

BiographyCandace Lerman

A little about me, I was diagnosed in 2014 with a rare blood disorder. After months of failing to control my disease, I researched and found my own treatment that put me into remission. Because of this, I was able to attend law school, graduate in only 2.5 years and pass the Florida Bar exam to become an attorney. I practice in health law and work with members of Congress on legislation including the 21st Century Cures Act. I'm also the face of HR 1223, the OPEN Act, which would incentivize pharmaceutical companies to repurpose products for rare diseases. I understand the delicate balance between patient representation and providing valuable insight to push the industry forward.

BiographyAndrea Ruano Flores

I am a 10 years cancer survivor. I was a teenage diagnosis and I have been dealing with side effects since 2008. I volunteer as an advocate and I am fully invested in improving the quality of life during and after cancer.